Literature DB >> 17511972

Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane.

Thomas J Spencer1, Joseph Biederman, Bertha K Madras, Darin D Dougherty, Ali A Bonab, Elijahu Livni, Peter C Meltzer, Jessica Martin, Scott Rauch, Alan J Fischman.   

Abstract

BACKGROUND: The dopamine transporter (DAT) is known to be a key regulator of dopamine, and recent studies of genetics, treatment, and imaging have highlighted the role of DAT in attention-deficit/hyperactivity disorder (ADHD). The findings of in vivo neuroimaging of DAT in ADHD have been somewhat discrepant, however.
METHOD: Dopamine transporter binding was measured using a highly selective ligand (C-11 altropane) and positron emission tomography (PET). The sample consisted of 47 well-characterized, treatment-naïve, nonsmoking, non-comorbid adults with and without ADHD. Additionally, control subjects had few symptoms of ADHD.
RESULTS: Results showed significantly increased DAT binding in the right caudate in adults with ADHD compared with matched control subjects without this disorder.
CONCLUSIONS: These results confirm abnormal DAT binding in the striatum of adults with ADHD and provide further support that dysregulation of DAT may be an important component of the pathophysiology of ADHD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17511972      PMCID: PMC2715944          DOI: 10.1016/j.biopsych.2006.12.008

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  19 in total

1.  Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder.

Authors:  Christopher H van Dyck; Donald M Quinlan; Lisa M Cretella; Julie K Staley; Robert T Malison; Ronald M Baldwin; John P Seibyl; Robert B Innis
Journal:  Am J Psychiatry       Date:  2002-02       Impact factor: 18.112

Review 2.  Molecular genetics of attention-deficit/hyperactivity disorder.

Authors:  Stephen V Faraone; Roy H Perlis; Alysa E Doyle; Jordan W Smoller; Jennifer J Goralnick; Meredith A Holmgren; Pamela Sklar
Journal:  Biol Psychiatry       Date:  2005-01-21       Impact factor: 13.382

3.  Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries.

Authors:  Christopher H van Dyck; John P Seibyl; Robert T Malison; Marc Laruelle; Sami S Zoghbi; Ronald M Baldwin; Robert B Innis
Journal:  Am J Geriatr Psychiatry       Date:  2002 Jan-Feb       Impact factor: 4.105

Review 4.  The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD).

Authors:  Bertha K Madras; Gregory M Miller; Alan J Fischman
Journal:  Behav Brain Res       Date:  2002-03-10       Impact factor: 3.332

5.  Striatal dopamine transporters and cognitive functioning in healthy men and women.

Authors:  L H Mozley; R C Gur; P D Mozley; R E Gur
Journal:  Am J Psychiatry       Date:  2001-09       Impact factor: 18.112

6.  Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.

Authors:  J Biederman; S V Faraone; T Spencer; T Wilens; D Norman; K A Lapey; E Mick; B K Lehman; A Doyle
Journal:  Am J Psychiatry       Date:  1993-12       Impact factor: 18.112

7.  Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder.

Authors:  Keun-Ah Cheon; Young Hoon Ryu; Young-Kee Kim; Kee Namkoong; Chan-Hyung Kim; Jong Doo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-11-29       Impact factor: 9.236

8.  PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate.

Authors:  Thomas J Spencer; Joseph Biederman; Patrick E Ciccone; Bertha K Madras; Darin D Dougherty; Ali A Bonab; Elijahu Livni; Dolly A Parasrampuria; Alan J Fischman
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

Review 9.  Overview and neurobiology of attention-deficit/hyperactivity disorder.

Authors:  Thomas J Spencer; Joseph Biederman; Timothy E Wilens; Stephen V Faraone
Journal:  J Clin Psychiatry       Date:  2002       Impact factor: 4.384

Review 10.  The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder.

Authors:  Klaus Henning Krause; Stefan H Dresel; Johanna Krause; Christian la Fougere; Manfred Ackenheil
Journal:  Neurosci Biobehav Rev       Date:  2003-11       Impact factor: 8.989

View more
  47 in total

1.  DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls.

Authors:  Yannis Paloyelis; Philip Asherson; Mitul A Mehta; Stephen V Faraone; Jonna Kuntsi
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

Review 2.  ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence.

Authors:  Scott H Kollins; R Alison Adcock
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-02-18       Impact factor: 5.067

3.  The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association Cortex.

Authors:  Amy F T Arnsten
Journal:  J Pediatr       Date:  2009-05-01       Impact factor: 4.406

4.  Response to Selveraj et al.

Authors:  S V Faraone; T J Spencer; B K Madras; Y Zhang-James; J Biederman
Journal:  Mol Psychiatry       Date:  2014-04-01       Impact factor: 15.992

5.  Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study.

Authors:  Corinde E Wiers; Falk W Lohoff; Jisoo Lee; Christine Muench; Clara Freeman; Amna Zehra; Stefano Marenco; Barbara K Lipska; Pavan K Auluck; Ningping Feng; Hui Sun; David Goldman; James M Swanson; Gene-Jack Wang; Nora D Volkow
Journal:  Eur J Neurosci       Date:  2018-08       Impact factor: 3.386

6.  Increased brain activity to unpleasant stimuli in individuals with the 7R allele of the DRD4 gene.

Authors:  Jean-G Gehricke; James M Swanson; Sophie Duong; Jenny Nguyen; Timothy L Wigal; James Fallon; Cyrus Caburian; Lutfi Tugan Muftuler; Robert K Moyzis
Journal:  Psychiatry Res       Date:  2014-11-04       Impact factor: 3.222

Review 7.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

8.  Functional analysis of upstream common polymorphisms of the dopamine transporter gene.

Authors:  Mikhil N Bamne; Michael E Talkowski; Kodavali V Chowdari; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2009-03-09       Impact factor: 9.306

Review 9.  Attention-deficit/hyperactivity disorder in older adults: prevalence and possible connections to mild cognitive impairment.

Authors:  Nikki Ivanchak; Kristen Fletcher; Gregory A Jicha
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

10.  Developmental psychopathology: Attention Deficit Hyperactivity Disorder (ADHD).

Authors:  Sören Schmidt; Franz Petermann
Journal:  BMC Psychiatry       Date:  2009-09-17       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.